February 13, 2025 Shields Health Solutions

Shields Outcomes 2024 Report

Shields PG1 Community Based Residency Program

For the fourth consecutive year, we are excited to share our industry-leading outcomes across our expansive network of health system partners. At Shields, we are committed to empowering patients and health systems, transforming challenges into boundless opportunities.

By partnering with the industry’s foremost leaders and employing an integrated care model founded on innovation and compassion, we work side by side with our partners to accelerate the success of their specialty pharmacy programs.

  • Shields continues to set the bar for specialty pharmacy outcomes in disease states such as Oncology, Rheumatoid Arthitris, HIV, Hepatitis C, Cystic Fibrosis, and more.
  • Our integrated specialty pharmacy care model removes barriers that often disrupt or fragment patient care, ensuring that individuals receive the specialty medications they need without unnecessary delays. 
  • Our commitment to enhancing patient health is driven by a state-of-the-art data analytics engine, which powers our innovative integrated care model.
  • In partnership with our healthcare providers and the broader community, we are dedicated to raising the standard of specialty pharmacy and ensuring that every interaction contributes to better health outcomes today and lays the foundation for a healthier tomorrow.